West Pharmaceutical Services (NYSE:WST) Issues FY 2025 Earnings Guidance

West Pharmaceutical Services (NYSE:WST) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 6.000-6.200 for the period, compared to the consensus EPS estimate of 7.430. The company issued revenue guidance of $2.9 billion-$2.9 billion, compared to the consensus revenue estimate of $3.0 billion.

Analyst Ratings Changes

Several analysts recently issued reports on WST shares. StockNews.com upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating in a report on Tuesday. UBS Group raised shares of West Pharmaceutical Services from a “neutral” rating to a “buy” rating and increased their price objective for the company from $350.00 to $390.00 in a research report on Thursday, December 12th. Citigroup started coverage on shares of West Pharmaceutical Services in a research note on Wednesday, January 8th. They issued a “buy” rating and a $400.00 target price for the company. Wolfe Research started coverage on shares of West Pharmaceutical Services in a report on Friday, December 13th. They set a “peer perform” rating for the company. Finally, Bank of America boosted their price objective on shares of West Pharmaceutical Services from $350.00 to $355.00 and gave the stock a “buy” rating in a report on Friday, December 13th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $403.75.

West Pharmaceutical Services Stock Down 36.4 %

Shares of WST stock traded down $117.20 during mid-day trading on Thursday, reaching $205.08. 3,721,251 shares of the company were exchanged, compared to its average volume of 560,491. The company has a market capitalization of $14.85 billion, a P/E ratio of 30.45, a P/E/G ratio of 19.31 and a beta of 1.01. The business’s 50 day simple moving average is $332.39 and its 200 day simple moving average is $315.13. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.23 and a current ratio of 3.00. West Pharmaceutical Services has a fifty-two week low of $201.82 and a fifty-two week high of $408.88.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, February 13th. The medical instruments supplier reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.07. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. Research analysts predict that West Pharmaceutical Services will post 6.67 earnings per share for the current year.

West Pharmaceutical Services Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 11th. Shareholders of record on Friday, February 7th were paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.41%. The ex-dividend date of this dividend was Friday, February 7th. West Pharmaceutical Services’s payout ratio is currently 12.46%.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.